Program Description
How confident are you in differentiating COPD from other chronic respiratory conditions? In this segment entitled The Lung in COPD: What's Left, hear Dr Stokes Peebles speak on improving diagnosis and symptom management in patients with COPD.
Hosted by
Mark Chyna, MD
Learning Objectives
Utilize lung function testing to direct pharmacologic and adjunctive treatment approaches in moderate to severe COPD
Target Audience
The target audience for this educational activity is physicians.
Faculty/Disclosures
Faculty:
R. Stokes Peebles, M.D., FAAAI
Dr. Peebles is on the Merck Advisory Board.
Clinical Editor:
Carolyn Skowronski, PharmD, discloses that she holds stock in Merck.
Educational Partner Disclosures:
Steven Folstein, Director of Education, American Academy of Allergy, Asthma and Immunology, has nothing to disclose.
Moderator:
Dr. Mark Chyna has nothing to disclose.
Accreditation
pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
pmiCME designates this educational activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Provider
This activity is co-sponsored by pmiCME and the Academy of Allergy, Asthma & Immunology
Pri-Med is a trusted communication and education platform for science and medicine that is owned by M|C Communications LLC. The Pri-Med brand represents a community of healthcare providers and their need to access the latest information and education through a network of meetings, resources, online, and new media tools. Pri-Med collaborates with leading institutions and distributes content developed by others through these channels.
Pri-Med's educational solutions are fully firewalled from the non-CME offerings and are developed compliantly and in accordance with accrediting organization requirements and standards, including the ACCME. Pri-Med's CME provides health care practitioners with access to evidence-based education through innovative learning formats designed to meet their individual needs. To learn more about Pri-Med, visit www.pri-med.com.
Commercial Support
pmiCME along with the American Academy of Allergy, Asthma & Immunology (AAAAI) are part of the ACES (Asthma and COPD Education Solutions) Consortium. This national CME initiative is a coordinated effort to improve the standards of care for patients with non-contagious chronic respiratory conditions. Funding for this initiative is obtained from multiple sources including commercial support. Receipt of these funds is project based and acknowledged by the partner organizations that are responsible for those identified projects.
pmiCME and AAAAI, through the University of North Texas Health Science Center at Fort Worth, receive funding from GlaxoSmithKline in support of this educational activity, which is part of the ACES Consortium initiative.
Instruction for Participation
This presentation may contain mention of unapproved or investigational therapeutic agents. Pri-Med Institute and this activity's commercial grantors do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Legal Disclaimer
To earn continuing education credit, simply listen to the podcast program. Learners must then complete a posttest and evaluation and receive a passing score of 70% or more on the posttest. Upon submission of the evaluation, learners will have the option of printing a certificate for their records.